<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01025752</url>
  </required_header>
  <id_info>
    <org_study_id>IIR 09-058</org_study_id>
    <nct_id>NCT01025752</nct_id>
  </id_info>
  <brief_title>Interactive Voice Response (IVR)-Based Treatment for Chronic Low Back Pain</brief_title>
  <official_title>IVR-based Cognitive Behavior Therapy for Chronic Low Back</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>VA Office of Research and Development</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>VA Office of Research and Development</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The proposed study will test how well an innovative method, interactive voice response (IVR),
      can be used for delivering an treatment for chronic low back pain. The use of IVR will
      improve the accessibility of treatment to Veterans. IVR is a computerized interface that
      allows patients to use their telephone to: 1) obtain pre-recorded didactic information, 2)
      report data regarding pain-related symptoms and adherence to pain coping skill practice, and
      3) receive personalized therapist feedback. Although CBT has been shown to be effective in
      reducing pain intensity, traditional CBT requires patients to make frequent office visits.
      The use of IVR will allow Veterans to access CBT from their home via a touch-tone telephone,
      thereby allowing them to access treatment at their convenience without travel to the VA for
      an outpatient appointment. Veterans with chronic low back pain will be randomized in equal
      numbers to receive either standard CBT or IVR-based CBT. Veterans in both conditions will
      receive 10 session of treatment designed to help them manage their chronic pain using pain
      coping skills. The primary outcome measure will be pain intensity.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES: The primary purpose of this study is to test the efficacy of an innovative
      method, interactive voice response (IVR), for delivering an empirically validated
      psychological (cognitive behavior therapy [CBT]) treatment for chronic pain in order to
      improve access and sustainability of this intervention. The primary clinical equivalence
      hypothesis states that Veterans with chronic low back pain (CLBP) receiving IVR-based CBT
      (ICBT) will demonstrate, relative to standard face-to-face CBT (CBT), equivalent declines in
      reports of pain intensity as measured by the numeric rating scale at post-treatment and
      follow-up. The secondary hypothesis states that Veterans with CLBP receiving ICBT, relative
      to CBT, will demonstrate equivalent declines in reports of pain-related interference and
      emotional distress at post-treatment and follow-up.

      RESEARCH DESIGN: A randomized design will be employed in which standard CBT (CBT) is compared
      to an Interactive CBT (ICBT) treatment condition. Participants will be randomized in equal
      numbers to both conditions. Repeated assessments of key outcome domains will occur at
      pretreatment/baseline and at 3 and 6 months following baseline.

      METHODOLOGY: Subjects will be 230 patients receiving care at the VA Connecticut Healthcare
      System who report chronic low back pain. The primary criteria for inclusion are constant pain
      of at least three months duration with at least a moderate level of average pain (i.e.,
      scores of 4 or greater on a 0 (no pain) to 10 (worst pain imaginable) on a numerical rating
      scale of average pain. All patients must have access to a touch-tone telephone. Excluded will
      be patients with life threatening or acute physical illness, current alcohol or substance
      abuse or dependence, current psychosis, suicidal ideation, dementia, and individuals seeking
      surgical pain treatment. Comprehensive evaluations will be conducted at each assessment
      interval. Following completion of written consent and an initial baseline evaluation,
      participants will be randomized to one of the two treatments. Sessions will be audiotaped to
      ensure the fidelity of the face-to-face CBT sessions and the personalized therapist feedback
      in the IVR-based CBT condition. Both conditions will involve 10 outpatient therapy sessions
      with a psychologist trained experienced in the delivery of these treatments. Adherence to
      coping skill practice will be assessed using IVR for both treatment groups. Analysis of
      primary and secondary outcome measures will employ mixed-effects models, which will account
      for the clustering induced by repeated measures on individual patients.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2011</start_date>
  <completion_date type="Actual">April 2016</completion_date>
  <primary_completion_date type="Actual">April 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Numeric Rating Scale of Pain Intensity</measure>
    <time_frame>post-treatment (12 weeks), 3 and 6 months post-baseline</time_frame>
    <description>An 11-point NRS for pain was administered to patients, with 0 representing &quot;No Pain&quot; and 10 representing &quot;Worst Possible Pain.&quot; Patients were asked to rate the level of pain that best represented their experience of worst pain, least pain and average pain over the past week. We computed the change from baseline.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in Multidimensional Pain Inventory Interference Subscale</measure>
    <time_frame>post-treatment (12 weeks), 3 and 6 months post-baseline</time_frame>
    <description>The interference subscale of the West Haven-Yale Multidimensional Pain Inventory (WHYMPI) assesses pain-related interference with quality of life. Scores ranging from 0-6, with higher scores indicating more interference. We computed the change from baseline.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Roland Morris Disability Questionnaire</measure>
    <time_frame>post-treatment (12 weeks), 3 and 6 months post-baseline</time_frame>
    <description>The RMDQ (Roland &amp; Morris, 1983) is a 24-item checklist designed for patients to identify the level of disability and functional status associated with chronic low back pain. Patients are instructed to endorse items that describe their functional status that day. Scores range from 0-24, with higher scores indicating more disability. We computed the change from baseline.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Veterans Short Form-36 Health Status Questionnaire: Physical Component Scale</measure>
    <time_frame>post-treatment (12 weeks), 3 and 6 months post-baseline</time_frame>
    <description>The SF-36V is an adaptation of the Medical Outcomes Study SF-36 (Ware &amp; Sherbourne, 1992) intended to apply to veteran-specific health-related quality of life. The SF-36 can also be divided into two aggregate summary measures the Physical Component Summary (PCS) and the Mental Component Summary (MCS). The lower the score, the more disability, range 0-100. We computed the change from baseline.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Veterans Short Form-36 Health Status Questionnaire: Mental Component Scale</measure>
    <time_frame>post-treatment (12 weeks), 3 and 6 months post-baseline</time_frame>
    <description>The SF-36V is an adaptation of the Medical Outcomes Study SF-36 (Ware &amp; Sherbourne, 1992) intended to apply to veteran-specific health-related quality of life. The SF-36 can also be divided into two aggregate summary measures the Physical Component Summary (PCS) and the Mental Component Summary (MCS). The lower the score, the more disability, range 0-100. We computed the change from baseline.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Beck Depression Inventory-II</measure>
    <time_frame>post-treatment (12 weeks), 3 and 6 months post-baseline</time_frame>
    <description>Depressive symptom severity was assessed using the BDI-II, higher scores indicate more depressive symptomology, range 0-63. We computed the change from baseline.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in Pittsburgh Sleep Quality Index</measure>
    <time_frame>post-treatment (12 weeks), 3 and 6 months post-baseline</time_frame>
    <description>The PSQI assess sleep quality, with lower scores indicating better sleep, range 0 to 21.We computed the change from baseline.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">134</enrollment>
  <condition>Chronic Low Back Pain</condition>
  <arm_group>
    <arm_group_label>Arm 1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ten session IVR-based cognitive behavior therapy intervention for chronic low back pain</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm 2</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Ten session face to face cognitive behavior therapy for chronic low back pain</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Face to face cognitive behavior therapy</intervention_name>
    <description>Ten session face to face cognitive behavior therapy for chronic low back pain</description>
    <arm_group_label>Arm 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>IVR based cognitive behavioral therapy</intervention_name>
    <description>Ten session cognitive behavior therapy for chronic low back pain using interactive voice response therapy</description>
    <arm_group_label>Arm 1</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  presence of at least a moderate level of pain (i.e., pain scores of &gt; or = 4) and
             presence of pain for a period of &gt; or = 3 months

          -  ability to participate safely in the walking portion of the intervention as evidenced
             by ability to walk at least one block

          -  availability of a touch-tone telephone and computer with internet access in the
             participant's residence

          -  Veteran receiving care at VA Connecticut Healthcare System

        Exclusion Criteria:

          -  life threatening or acute medical condition that could impair participation (e.g.,
             severe chronic obstructive pulmonary disease, lower limb amputation, terminal cancer);

          -  psychiatric condition (e.g., active substance abuse, psychosis or suicidality) that
             could impair participation

          -  surgical interventions for pain during their participation in this study

          -  sensory deficits that would impair participation (e.g., hearing loss to a degree that
             telephone usage is not possible).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alicia A. Heapy, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>VA Connecticut Healthcare System West Haven Campus, West Haven, CT</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>VA Connecticut Healthcare System West Haven Campus, West Haven, CT</name>
      <address>
        <city>West Haven</city>
        <state>Connecticut</state>
        <zip>06516</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Heapy AA, Higgins DM, LaChappelle KM, Kirlin J, Goulet JL, Czlapinski RA, Buta E, Piette JD, Krein SL, Richardson CR, Kerns RD. Cooperative pain education and self-management (COPES): study design and protocol of a randomized non-inferiority trial of an interactive voice response-based self-management intervention for chronic low back pain. BMC Musculoskelet Disord. 2016 Feb 16;17:85. doi: 10.1186/s12891-016-0924-z.</citation>
    <PMID>26879051</PMID>
  </results_reference>
  <verification_date>October 2017</verification_date>
  <study_first_submitted>December 3, 2009</study_first_submitted>
  <study_first_submitted_qc>December 3, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 4, 2009</study_first_posted>
  <results_first_submitted>June 1, 2017</results_first_submitted>
  <results_first_submitted_qc>October 31, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">August 3, 2018</results_first_posted>
  <last_update_submitted>October 31, 2017</last_update_submitted>
  <last_update_submitted_qc>October 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>chronic pain</keyword>
  <keyword>cognitive behavior therapy</keyword>
  <keyword>low back pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Veterans with chronic back pain from VA Connecticut Healthcare System and surrounding community areas were recruited from June 2012-July 2015.</recruitment_details>
      <pre_assignment_details>Eligibility screening was conducted by the research assistant via interview and medical record review. Participants who enrolled then subsequently found ineligible from further baseline assessment questionnaires were not randomized to a treatment arm, and excluded from the study (i.e. substance abuse, severe depression, cognitive impairment), n=9.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Arm 1: IVR CBT</title>
          <description>Ten session IVR-based cognitive behavior therapy for chronic low back pain
IVR based cognitive behavioral therapy: Ten session cognitive behavior therapy for chronic low back pain using interactive voice response therapy</description>
        </group>
        <group group_id="P2">
          <title>Arm 2: F2F CBT</title>
          <description>Ten session face to face cognitive behavior therapy for chronic low back pain
Face to face cognitive behavior therapy: Ten session face to face cognitive behavior therapy for chronic low back pain</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="62"/>
                <participants group_id="P2" count="63"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="54"/>
                <participants group_id="P2" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>134 participants were consented, 9 failed baseline screening measures and 125 were randomized to either IVR CBT or F2F CBT.</population>
      <group_list>
        <group group_id="B1">
          <title>Arm 1: IVR CBT</title>
          <description>Ten session IVR-based cognitive behavior therapy for chronic low back pain
IVR based cognitive behavioral therapy: Ten session cognitive behavior therapy for chronic low back pain using interactive voice response therapy</description>
        </group>
        <group group_id="B2">
          <title>Arm 2: F2F CBT</title>
          <description>Ten session face to face cognitive behavior therapy for chronic low back pain
Face to face cognitive behavior therapy: Ten session face to face cognitive behavior therapy for chronic low back pain</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="62"/>
            <count group_id="B2" value="63"/>
            <count group_id="B3" value="125"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="59.2" spread="11.8"/>
                    <measurement group_id="B2" value="56.7" spread="11.5"/>
                    <measurement group_id="B3" value="57.9" spread="11.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="13"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="28"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="49"/>
                    <measurement group_id="B2" value="48"/>
                    <measurement group_id="B3" value="97"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Balck, not Hispanic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Hispanic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White, not Hispanic</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="43"/>
                    <measurement group_id="B2" value="37"/>
                    <measurement group_id="B3" value="80"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="62"/>
                    <measurement group_id="B2" value="63"/>
                    <measurement group_id="B3" value="125"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Numeric Rating Scale of Pain Intensity</title>
        <description>An 11-point NRS for pain was administered to patients, with 0 representing &quot;No Pain&quot; and 10 representing &quot;Worst Possible Pain.&quot; Patients were asked to rate the level of pain that best represented their experience of worst pain, least pain and average pain over the past week. We computed the change from baseline.</description>
        <time_frame>post-treatment (12 weeks), 3 and 6 months post-baseline</time_frame>
        <population>The number analyzed in rows differs because we analyzed the available follow-up questionnaire data for each participant (some participants did not complete the questionnaires at all time points).</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 1: IVR CBT</title>
            <description>Ten session IVR-based cognitive behavior therapy for chronic low back pain
IVR based cognitive behavioral therapy: Ten session cognitive behavior therapy for chronic low back pain using interactive voice response therapy</description>
          </group>
          <group group_id="O2">
            <title>Arm 2: F2F CBT</title>
            <description>Ten session face to face cognitive behavior therapy for chronic low back pain
Face to face cognitive behavior therapy: Ten session face to face cognitive behavior therapy for chronic low back pain</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Numeric Rating Scale of Pain Intensity</title>
          <description>An 11-point NRS for pain was administered to patients, with 0 representing &quot;No Pain&quot; and 10 representing &quot;Worst Possible Pain.&quot; Patients were asked to rate the level of pain that best represented their experience of worst pain, least pain and average pain over the past week. We computed the change from baseline.</description>
          <population>The number analyzed in rows differs because we analyzed the available follow-up questionnaire data for each participant (some participants did not complete the questionnaires at all time points).</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>post-treatment (12 weeks)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="52"/>
                    <count group_id="O2" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.77" lower_limit="-1.29" upper_limit="-0.26"/>
                    <measurement group_id="O2" value="-0.84" lower_limit="-1.39" upper_limit="-0.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 months post-baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="49"/>
                    <count group_id="O2" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.23" lower_limit="-1.73" upper_limit="-0.72"/>
                    <measurement group_id="O2" value="-1.00" lower_limit="-1.52" upper_limit="-0.48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months post-baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="49"/>
                    <count group_id="O2" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.51" lower_limit="-1.06" upper_limit="0.04"/>
                    <measurement group_id="O2" value="-0.44" lower_limit="-1.01" upper_limit="0.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>post-treatment (12 weeks) time point</groups_desc>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>A 20% (1.4) reduction in NRS for pain intensity from baseline was considered minimally clinically important the non-inferiority margin was set at one NRS unit. The required sample size was 230 participants. Because enrollment was slower than expected and the standard deviation in the primary outcome was less than the initial power calculation (1.6 vs. 2.45) we conducted a sample size recalculation, based on observed data to determine that we would need 42 completers per arm for 80% power.</non_inferiority_desc>
            <p_value>0.007</p_value>
            <p_value_desc>Non-inferiority margin of 1</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>The models includes treatment arm, time, treatment-by-time interaction, baseline NRS, stratification variables (distance from VA &amp; back pain cause)</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.07</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.67</ci_lower_limit>
            <ci_upper_limit>0.80</ci_upper_limit>
            <estimate_desc>The upper limit (0.80) fell below the non-inferiority margin of 1.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>3 month post-baseline time point</groups_desc>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>A 20% (1.4) reduction in NRS for pain intensity from baseline was considered minimally clinically important the non-inferiority margin was set at one NRS unit. The required sample size was 230 participants. Because enrollment was slower than expected and the standard deviation in the primary outcome was less than the initial power calculation (1.6 vs. 2.45) we conducted a sample size recalculation, based on observed data to determine that we would need 42 completers per arm for 80% power.</non_inferiority_desc>
            <p_value>&lt;0.0001</p_value>
            <p_value_desc>Non-inferiority margin of 1</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>The models includes treatment arm, time, treatment-by-time interaction, baseline NRS, stratification variables (distance from VA &amp; back pain cause)</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.23</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.94</ci_lower_limit>
            <ci_upper_limit>0.49</ci_upper_limit>
            <estimate_desc>The upper limit (0.49) fell below the non-inferiority margin of 1.</estimate_desc>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>6 month post- baseline time point.</groups_desc>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>A 20% (1.4) reduction in NRS for pain intensity from baseline was considered minimally clinically important the non-inferiority margin was set at one NRS unit. The required sample size was 230 participants. Because enrollment was slower than expected and the standard deviation in the primary outcome was less than the initial power calculation (1.6 vs. 2.45) we conducted a sample size recalculation, based on observed data to determine that we would need 42 completers per arm for 80% power.</non_inferiority_desc>
            <p_value>0.004</p_value>
            <p_value_desc>The non-inferiority margin is 1.</p_value_desc>
            <method>Mixed Models Analysis</method>
            <method_desc>The models includes treatment arm, time, treatment-by-time interaction, baseline NRS, stratification variables (distance from VA &amp; back pain cause)</method_desc>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.08</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.86</ci_lower_limit>
            <ci_upper_limit>0.71</ci_upper_limit>
            <estimate_desc>The upper limit (0.71) fell below the non-inferiority margin of 1.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Multidimensional Pain Inventory Interference Subscale</title>
        <description>The interference subscale of the West Haven-Yale Multidimensional Pain Inventory (WHYMPI) assesses pain-related interference with quality of life. Scores ranging from 0-6, with higher scores indicating more interference. We computed the change from baseline.</description>
        <time_frame>post-treatment (12 weeks), 3 and 6 months post-baseline</time_frame>
        <population>The number analyzed in rows differs because we analyzed the available follow-up questionnaire data for each participant (some participants did not complete the questionnaires at all time points).</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 1: IVR CBT</title>
            <description>Ten session IVR-based cognitive behavior therapy for chronic low back pain
IVR based cognitive behavioral therapy: Ten session cognitive behavior therapy for chronic low back pain using interactive voice response therapy</description>
          </group>
          <group group_id="O2">
            <title>Arm 2: F2F CBT</title>
            <description>Ten session face to face cognitive behavior therapy for chronic low back pain
Face to face cognitive behavior therapy: Ten session face to face cognitive behavior therapy for chronic low back pain</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Multidimensional Pain Inventory Interference Subscale</title>
          <description>The interference subscale of the West Haven-Yale Multidimensional Pain Inventory (WHYMPI) assesses pain-related interference with quality of life. Scores ranging from 0-6, with higher scores indicating more interference. We computed the change from baseline.</description>
          <population>The number analyzed in rows differs because we analyzed the available follow-up questionnaire data for each participant (some participants did not complete the questionnaires at all time points).</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="53"/>
                <count group_id="O2" value="51"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>post-treatment (12 weeks)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="51"/>
                    <count group_id="O2" value="43"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.37" lower_limit="-0.66" upper_limit="-0.08"/>
                    <measurement group_id="O2" value="-0.04" lower_limit="-0.35" upper_limit="0.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 months post-baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.37" lower_limit="-0.73" upper_limit="0.00"/>
                    <measurement group_id="O2" value="-0.02" lower_limit="-0.40" upper_limit="0.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months post-baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.12" lower_limit="-0.50" upper_limit="0.26"/>
                    <measurement group_id="O2" value="-0.09" lower_limit="-0.48" upper_limit="0.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Post-treatment (12 weeks) time point. (Mean difference of IVR CBT- F2F CBT)</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.12</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.33</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.74</ci_lower_limit>
            <ci_upper_limit>0.09</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>3 months post-baseline time point. (Mean difference of IVR CBT- F2F CBT)</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.20</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.34</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.87</ci_lower_limit>
            <ci_upper_limit>0.18</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>6 months post baseline time point. (Mean difference of IVR CBT- F2F CBT)</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.93</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.02</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.57</ci_lower_limit>
            <ci_upper_limit>0.52</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Roland Morris Disability Questionnaire</title>
        <description>The RMDQ (Roland &amp; Morris, 1983) is a 24-item checklist designed for patients to identify the level of disability and functional status associated with chronic low back pain. Patients are instructed to endorse items that describe their functional status that day. Scores range from 0-24, with higher scores indicating more disability. We computed the change from baseline.</description>
        <time_frame>post-treatment (12 weeks), 3 and 6 months post-baseline</time_frame>
        <population>The number analyzed in rows differs because we analyzed the available follow-up questionnaire data for each participant (some participants did not complete the questionnaires at all time points).</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 1: IVR CBT</title>
            <description>Ten session IVR-based cognitive behavior therapy for chronic low back pain
IVR based cognitive behavioral therapy: Ten session cognitive behavior therapy for chronic low back pain using interactive voice response therapy</description>
          </group>
          <group group_id="O2">
            <title>Arm 2: F2F CBT</title>
            <description>Ten session face to face cognitive behavior therapy for chronic low back pain
Face to face cognitive behavior therapy: Ten session face to face cognitive behavior therapy for chronic low back pain</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Roland Morris Disability Questionnaire</title>
          <description>The RMDQ (Roland &amp; Morris, 1983) is a 24-item checklist designed for patients to identify the level of disability and functional status associated with chronic low back pain. Patients are instructed to endorse items that describe their functional status that day. Scores range from 0-24, with higher scores indicating more disability. We computed the change from baseline.</description>
          <population>The number analyzed in rows differs because we analyzed the available follow-up questionnaire data for each participant (some participants did not complete the questionnaires at all time points).</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="53"/>
                <count group_id="O2" value="51"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>post-treatment (12 weeks)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="51"/>
                    <count group_id="O2" value="43"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.92" lower_limit="-4.16" upper_limit="-1.69"/>
                    <measurement group_id="O2" value="-2.42" lower_limit="-3.74" upper_limit="-1.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 months post-baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-3.38" lower_limit="-4.75" upper_limit="-2.02"/>
                    <measurement group_id="O2" value="-1.86" lower_limit="-3.25" upper_limit="-0.46"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months post-baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="48"/>
                    <count group_id="O2" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.63" lower_limit="-3.90" upper_limit="-1.35"/>
                    <measurement group_id="O2" value="-2.02" lower_limit="-3.32" upper_limit="-0.71"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>post-treatment (12 weeks) time point</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.58</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.50</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.29</ci_lower_limit>
            <ci_upper_limit>1.29</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>3 months post-baseline time point</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.12</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-1.53</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-3.46</ci_lower_limit>
            <ci_upper_limit>0.41</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>6 months post-baseline time point</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.51</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.61</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.42</ci_lower_limit>
            <ci_upper_limit>1.20</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Veterans Short Form-36 Health Status Questionnaire: Physical Component Scale</title>
        <description>The SF-36V is an adaptation of the Medical Outcomes Study SF-36 (Ware &amp; Sherbourne, 1992) intended to apply to veteran-specific health-related quality of life. The SF-36 can also be divided into two aggregate summary measures the Physical Component Summary (PCS) and the Mental Component Summary (MCS). The lower the score, the more disability, range 0-100. We computed the change from baseline.</description>
        <time_frame>post-treatment (12 weeks), 3 and 6 months post-baseline</time_frame>
        <population>The number analyzed in rows differs because we analyzed the available follow-up questionnaire data for each participant (some participants did not complete the questionnaires at all time points).</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 1: IVR CBT</title>
            <description>Ten session IVR-based cognitive behavior therapy for chronic low back pain
IVR based cognitive behavioral therapy: Ten session cognitive behavior therapy for chronic low back pain using interactive voice response therapy</description>
          </group>
          <group group_id="O2">
            <title>Arm 2: F2F CBT</title>
            <description>Ten session face to face cognitive behavior therapy for chronic low back pain
Face to face cognitive behavior therapy: Ten session face to face cognitive behavior therapy for chronic low back pain</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Veterans Short Form-36 Health Status Questionnaire: Physical Component Scale</title>
          <description>The SF-36V is an adaptation of the Medical Outcomes Study SF-36 (Ware &amp; Sherbourne, 1992) intended to apply to veteran-specific health-related quality of life. The SF-36 can also be divided into two aggregate summary measures the Physical Component Summary (PCS) and the Mental Component Summary (MCS). The lower the score, the more disability, range 0-100. We computed the change from baseline.</description>
          <population>The number analyzed in rows differs because we analyzed the available follow-up questionnaire data for each participant (some participants did not complete the questionnaires at all time points).</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="48"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>post-treatment (12 weeks)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                    <count group_id="O2" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.20" lower_limit="0.43" upper_limit="3.96"/>
                    <measurement group_id="O2" value="1.91" lower_limit="0.01" upper_limit="3.81"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 months post-baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="45"/>
                    <count group_id="O2" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.05" lower_limit="0.09" upper_limit="4.02"/>
                    <measurement group_id="O2" value="0.90" lower_limit="-1.15" upper_limit="2.95"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months post-baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="45"/>
                    <count group_id="O2" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.50" lower_limit="-0.44" upper_limit="3.45"/>
                    <measurement group_id="O2" value="2.09" lower_limit="0.03" upper_limit="4.14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>post-treatment (12 weeks) time point. (Mean difference of IVR CBT- F2F CBT)</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.83</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.29</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.30</ci_lower_limit>
            <ci_upper_limit>2.87</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>3 months post-baseline time point. (Mean difference of IVR CBT- F2F CBT)</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.42</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>1.15</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.68</ci_lower_limit>
            <ci_upper_limit>3.98</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>6 months post-baseline time point. (Mean difference of IVR CBT- F2F CBT)</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.68</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.58</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-3.40</ci_lower_limit>
            <ci_upper_limit>2.24</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Veterans Short Form-36 Health Status Questionnaire: Mental Component Scale</title>
        <description>The SF-36V is an adaptation of the Medical Outcomes Study SF-36 (Ware &amp; Sherbourne, 1992) intended to apply to veteran-specific health-related quality of life. The SF-36 can also be divided into two aggregate summary measures the Physical Component Summary (PCS) and the Mental Component Summary (MCS). The lower the score, the more disability, range 0-100. We computed the change from baseline.</description>
        <time_frame>post-treatment (12 weeks), 3 and 6 months post-baseline</time_frame>
        <population>The number analyzed in rows differs because we analyzed the available follow-up questionnaire data for each participant (some participants did not complete the questionnaires at all time points).</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 1: IVR CBT</title>
            <description>Ten session IVR-based cognitive behavior therapy for chronic low back pain
IVR based cognitive behavioral therapy: Ten session cognitive behavior therapy for chronic low back pain using interactive voice response therapy</description>
          </group>
          <group group_id="O2">
            <title>Arm 2: F2F CBT</title>
            <description>Ten session face to face cognitive behavior therapy for chronic low back pain
Face to face cognitive behavior therapy: Ten session face to face cognitive behavior therapy for chronic low back pain</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Veterans Short Form-36 Health Status Questionnaire: Mental Component Scale</title>
          <description>The SF-36V is an adaptation of the Medical Outcomes Study SF-36 (Ware &amp; Sherbourne, 1992) intended to apply to veteran-specific health-related quality of life. The SF-36 can also be divided into two aggregate summary measures the Physical Component Summary (PCS) and the Mental Component Summary (MCS). The lower the score, the more disability, range 0-100. We computed the change from baseline.</description>
          <population>The number analyzed in rows differs because we analyzed the available follow-up questionnaire data for each participant (some participants did not complete the questionnaires at all time points).</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="52"/>
                <count group_id="O2" value="48"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>post-treatment (12 weeks)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                    <count group_id="O2" value="40"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.67" lower_limit="-0.36" upper_limit="3.71"/>
                    <measurement group_id="O2" value="0.42" lower_limit="-1.74" upper_limit="2.59"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 months post-baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="45"/>
                    <count group_id="O2" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.39" lower_limit="-0.86" upper_limit="3.64"/>
                    <measurement group_id="O2" value="1.01" lower_limit="-1.33" upper_limit="3.35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months post-baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="45"/>
                    <count group_id="O2" value="41"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.96" lower_limit="-1.41" upper_limit="3.33"/>
                    <measurement group_id="O2" value="-1.47" lower_limit="-3.96" upper_limit="1.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>post-treatment (12 weeks) time point. (Mean difference of IVR CBT- F2F CBT)</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.40</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>1.25</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.66</ci_lower_limit>
            <ci_upper_limit>4.16</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>3 months post-baseline. (Mean difference of IVR CBT- F2F CBT)</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.81</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.38</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.82</ci_lower_limit>
            <ci_upper_limit>3.58</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>6 months post-baseline time point. (Mean difference of IVR CBT- F2F CBT)</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.16</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>2.43</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-0.96</ci_lower_limit>
            <ci_upper_limit>5.82</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Beck Depression Inventory-II</title>
        <description>Depressive symptom severity was assessed using the BDI-II, higher scores indicate more depressive symptomology, range 0-63. We computed the change from baseline.</description>
        <time_frame>post-treatment (12 weeks), 3 and 6 months post-baseline</time_frame>
        <population>The number analyzed in rows differs because we analyzed the available follow-up questionnaire data for each participant (some participants did not complete the questionnaires at all time points).</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 1: IVR CBT</title>
            <description>Ten session IVR-based cognitive behavior therapy for chronic low back pain
IVR based cognitive behavioral therapy: Ten session cognitive behavior therapy for chronic low back pain using interactive voice response therapy</description>
          </group>
          <group group_id="O2">
            <title>Arm 2: F2F CBT</title>
            <description>Ten session face to face cognitive behavior therapy for chronic low back pain
Face to face cognitive behavior therapy: Ten session face to face cognitive behavior therapy for chronic low back pain</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Beck Depression Inventory-II</title>
          <description>Depressive symptom severity was assessed using the BDI-II, higher scores indicate more depressive symptomology, range 0-63. We computed the change from baseline.</description>
          <population>The number analyzed in rows differs because we analyzed the available follow-up questionnaire data for each participant (some participants did not complete the questionnaires at all time points).</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="54"/>
                <count group_id="O2" value="51"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>post-treatment (12 weeks)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="52"/>
                    <count group_id="O2" value="43"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.00" lower_limit="-2.79" upper_limit="0.78"/>
                    <measurement group_id="O2" value="-1.25" lower_limit="-3.14" upper_limit="0.65"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 months post-baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="49"/>
                    <count group_id="O2" value="46"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.49" lower_limit="-2.61" upper_limit="1.64"/>
                    <measurement group_id="O2" value="0.78" lower_limit="-1.40" upper_limit="2.96"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months post-baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="49"/>
                    <count group_id="O2" value="45"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.89" lower_limit="-1.62" upper_limit="3.40"/>
                    <measurement group_id="O2" value="1.62" lower_limit="-0.97" upper_limit="4.21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>post-treatment (12 weeks time point). (Mean difference of IVR CBT- F2F CBT)</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.85</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.24</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.32</ci_lower_limit>
            <ci_upper_limit>2.80</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>3 months post-baseline time point. (Mean difference of IVR CBT- F2F CBT)</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.40</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-1.27</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-4.27</ci_lower_limit>
            <ci_upper_limit>1.73</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>6 months post-baseline time point. (Mean difference of IVR CBT- F2F CBT)</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.68</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.74</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-4.30</ci_lower_limit>
            <ci_upper_limit>2.83</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Change in Pittsburgh Sleep Quality Index</title>
        <description>The PSQI assess sleep quality, with lower scores indicating better sleep, range 0 to 21.We computed the change from baseline.</description>
        <time_frame>post-treatment (12 weeks), 3 and 6 months post-baseline</time_frame>
        <population>The number analyzed in rows differs because we analyzed the available follow-up questionnaire data for each participant (some participants did not complete the questionnaires at all time points).</population>
        <group_list>
          <group group_id="O1">
            <title>Arm 1: IVR CBT</title>
            <description>Ten session IVR-based cognitive behavior therapy for chronic low back pain
IVR based cognitive behavioral therapy: Ten session cognitive behavior therapy for chronic low back pain using interactive voice response therapy</description>
          </group>
          <group group_id="O2">
            <title>Arm 2: F2F CBT</title>
            <description>Ten session face to face cognitive behavior therapy for chronic low back pain
Face to face cognitive behavior therapy: Ten session face to face cognitive behavior therapy for chronic low back pain</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Pittsburgh Sleep Quality Index</title>
          <description>The PSQI assess sleep quality, with lower scores indicating better sleep, range 0 to 21.We computed the change from baseline.</description>
          <population>The number analyzed in rows differs because we analyzed the available follow-up questionnaire data for each participant (some participants did not complete the questionnaires at all time points).</population>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="49"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>post-treatment (12 weeks)</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="47"/>
                    <count group_id="O2" value="38"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2.03" lower_limit="-2.94" upper_limit="-1.12"/>
                    <measurement group_id="O2" value="-1.09" lower_limit="-2.06" upper_limit="-0.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 months post-baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="45"/>
                    <count group_id="O2" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1.33" lower_limit="-2.21" upper_limit="-0.44"/>
                    <measurement group_id="O2" value="-1.21" lower_limit="-2.12" upper_limit="-0.29"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6 months post-baseline</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="44"/>
                    <count group_id="O2" value="42"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.87" lower_limit="-1.99" upper_limit="0.24"/>
                    <measurement group_id="O2" value="-1.25" lower_limit="-2.38" upper_limit="-0.11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>post-treatment (12 weeks) time point. (Mean difference of IVR CBT- F2F CBT)</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.17</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.94</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-2.28</ci_lower_limit>
            <ci_upper_limit>0.40</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>3 months post-baseline time point. (Mean difference of IVR CBT- F2F CBT)</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.86</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>-0.12</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.39</ci_lower_limit>
            <ci_upper_limit>1.16</ci_upper_limit>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>6 months post-baseline time point. (Mean difference of IVR CBT- F2F CBT)</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>0.64</p_value>
            <method>Mixed Models Analysis</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.37</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>-1.22</ci_lower_limit>
            <ci_upper_limit>1.97</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Arm 1: IVR CBT</title>
          <description>Ten session IVR-based cognitive behavior therapy for chronic low back pain
IVR based cognitive behavioral therapy: Ten session cognitive behavior therapy for chronic low back pain using interactive voice response therapy</description>
        </group>
        <group group_id="E2">
          <title>Arm 2: F2F CBT</title>
          <description>Ten session face to face cognitive behavior therapy for chronic low back pain
Face to face cognitive behavior therapy: Ten session face to face cognitive behavior therapy for chronic low back pain</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="63"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiac disorder event</sub_title>
                <description>Unrelated to study</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="62"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="63"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Infection of foot lesion</sub_title>
                <description>Unrelated to study</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="62"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="63"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="14" subjects_at_risk="62"/>
                <counts group_id="E2" subjects_affected="19" subjects_at_risk="63"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Trip or Fall</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="62"/>
                <counts group_id="E2" events="7" subjects_affected="6" subjects_at_risk="63"/>
              </event>
              <event>
                <sub_title>Muscle or joint pain increase</sub_title>
                <counts group_id="E1" events="19" subjects_affected="11" subjects_at_risk="62"/>
                <counts group_id="E2" events="19" subjects_affected="15" subjects_at_risk="63"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Alicia Heapy</name_or_title>
      <organization>VA Connecticut Healthcare System</organization>
      <phone>203-932-5711 ext 2299</phone>
      <email>alicia.heapy@va.gov</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

